Human Platelet Antigen (HPA) polymorphism can lead to alloimmunization that clinically can manifest as neonatal alloimmune thrombocytopenia or post-transfusion thrombocytopenia purpura. HPA-1 genotyping allows screening for potential neonatal immunization in pregnancy
5.0 mL Whole Blood in (two) Lavender Top Tube(s) - EDTA
7 days Ambient
14 days Refrigerated
1.0 mL Whole Blood
Refer to Interpretive Results
Human Platelet Antigen (HPA) polymorphism can lead to alloimmunization that clinically can manifest as neonatal alloimmune thrombocytopenia or post-transfusion thrombocytopenia purpura. HPA-1 genotyping allows screening for potential neonatal immunization in pregnancy
2 to 4 days
00917603
81105